- MyIllumina
- Tools
Discover what NGS can do for your research
New opportunities and applications fueled by next-generation sequencing.
Read our introduction »
See how NGS is driving new cancer research discoveries
Dr. Hiroyuki Mano is adapting cutting-edge science to identify new therapeutic targets for cancer patients.
Read his story »
Watch the
MiSeq Webinar
How next-gen sequencing is revolutionizing cancer diagnoses
Join Dr. Andrew Fellowes of the Peter MacCallum Cancer Centre on April 26, as he discusses how his team uses the MiSeq system and TruSeq Amplicon - Cancer Panel for comprehensive profiling of tumor samples for a wider range of mutations than is possible with traditional technologies.
Resources
Explore new Illumina sequencing solutions for key cancer research applications
Download the data sheet »
Discover the value of archival FFPE samples using Illumina's array-based technology
Learn more »
Cancer analysis service from Illumina Genome Network
Learn more »
Comprehensive Cancer Research Portfolio
From structural and genetic variation, to gene expression and epigenetic modifcations, Illumina offers integrated sequencing, array, and real-time PCR solutions that empower scientists to examine the human genome, epigenome, and transcriptome at a depth and resolution that was previously unachievable.
Download the Tools for Cancer Genomics brochure (PDF)
Download the Cancer Initiative Flyer (PDF)
-
Sequencing
-
Arrays
-
Sequencing + Arrays
-
Multiplexed Analysis
-
Real-time PCR
| Sequencing | Arrays | Sequencing + Arrays | Multiplexed Analysis | Real-Time PCR | |
|---|---|---|---|---|---|
| Structural Variation | |||||
| CNV Screening |
|
|
|
|
|
| CNV Discovery |
|
|
|
||
| Breakpoint Mapping |
|
|
|||
| Indel & Translocation Mapping |
|
|
|
|
|
| Gene Expression | |||||
| Whole Genome |
|
|
|
||
| Focused |
|
||||
| Small RNA Discovery |
|
|
|||
| Small RNA Profiling |
|
|
|
||
| Epignetic Changes | |||||
| Methylation Biomarkers |
|
|
|
|
|
| Methylation Discovery |
|
|
|||
| DNA-protien Interactions |
|
|
|||
| Genetic Variation | |||||
| Whole-genome Genotyping |
|
|
|
||
| Custom/Focused Genotyping |
|
|
|
|
|
| SNV Discovery |
|
|
|||
| Whole-genome Sequencing |
|
|
|||
| Exome Sequencing |
|
|
|||
| Custom Enrichment |
|
||||
| Amplicon Sequencing |
|
||||
| Cancer Amplicon Sequencing |
|
||||
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.